保乳治疗中电子线追加照射相关放射性肺炎的危险因素回顾性分析
该单中心回顾性研究纳入2013至2019年接受保乳治疗的105例乳腺癌患者,全乳照射50 Gy后对瘤床行10 Gy电子线追加照射。结果显示,中央肺距离≥1.8 cm、电子线能量≥12 MeV及V1.25≥24 cm3与放射性肺炎发生相关,但严重放射性肺炎发生率不高。
要点
- 中央肺距离≥1.8 cm、电子线能量≥12 MeV和V1.25≥24 cm3是放射性肺炎的危险因素。
- 1级放射性肺炎发生率为20.6%,2级为0.93%,严重放射性肺炎发生率不高。
- 接受高能量电子线治疗及中央肺距离较大的患者应密切监测。
核心结论
- 中央肺距离≥1.8 cm、电子线能量≥12 MeV和V1.25≥24 cm3是与放射性肺炎相关的危险因素。
- 尽管严重放射性肺炎发生率不高,接受高能量电子线治疗和中央肺距离较大的患者仍应密切监测。
研究设计与样本
- 单中心回顾性研究,纳入2013至2019年接受保乳治疗的乳腺癌患者105例,中位年龄62岁(范围33-85),中位随访5个月。
- 放疗方案为全乳照射50 Gy后对瘤床行10 Gy电子线追加照射,电子线能量为4、6、9、12和15 MeV。
- 计算肺接受≥1.25 Gy的体积(V1.25),所有患者在照射后1年内接受计算机断层扫描和正电子发射断层扫描/计算机断层扫描,影像评估基于不良事件通用术语标准第5版。
主要发现
- 电子线追加照射野平均面积为72 cm2(范围36-196)。
- 在电子线照射野内,1级放射性肺炎发生于22例(20.6%)患者,2级放射性肺炎发生于1例(0.93%)患者。
- 电子线能量和V1.25的截断值分别为12 MeV和24 cm3。
关键数值与推荐
- 电子线能量截断值为12 MeV。
- V1.25截断值为24 cm3。
- 中央肺距离≥1.8 cm、电子线能量≥12 MeV和V1.25≥24 cm3为放射性肺炎的危险因素。
临床怎么用
- 对接受保乳治疗电子线追加照射的患者,应评估中央肺距离、电子线能量和V1.25。
- 对中央肺距离≥1.8 cm或使用电子线能量≥12 MeV的患者,应密切监测放射性肺炎。
局限性
- 本研究为单中心回顾性研究,样本量为105例,中位随访时间仅5个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to investigate risk factors for radiation pneumonitis (RP) caused by electron beam (EB) boost irradiation during breast-conserving therapy. METHODS AND MATERIALS: This single-institution retrospective study included patients with breast cancer treated with breast-conserving therapy from 2013 to 2019. Radiation therapy comprised whole-breast irradiation with a dose of 50 Gy and 10 Gy EB boost dose to the tumor bed. EB energies were 4, 6, 9, 12, and 15 MeV. The lung volume receiving ≥1.25 Gy (V1.25) was calculated and considered because the EB energies have a short range. All patients underwent computed tomography and positron emission tomography/computed tomography within 1 year of irradiation. Imaging evaluation was based on the Common Terminology Criteria for Adverse Events, version 5.0. RESULTS: Overall, 105 patients (median age, 62 years; range, 33-85) were included for analysis with a median follow-up period of 5 months. Average area of EB boost irradiation was 72 cm2 (range, 36-196). Grade 1 RP developed in the EB irradiation field in 22 (20.6%) patients; grade 2 RP developed in 1 (0.93%) patient. Even in patients with central lung distance (CLD) ≥1.8 cm, a positive correlation was found between RP and both energy (r = 0.36; P = .005) and V1.25 (r = 0.26; P = .04). No correlation was found between RP and irradiation field size (P = .47). The EB energy and V1.25 cutoff values were 12 MeV and 24 cm3, respectively. CONCLUSIONS: CLD of ≥1.8 cm, EB energy of ≥12 MeV, and V1.25 of ≥24 cm3 were risk factors associated with RP. Although the frequency of severe RP was not high, patients receiving high-energy electron treatment and those with a large CLD should be closely monitored.
引用
- Kawakami W, Takamatsu S, Taka M, et al. Factors Associated With Radiation Pneumonitis in Patients Receiving Electron Boost Radiation for Breast-Conserving Therapy: A Retrospective Review. Adv Radiat Oncol. 2020. PMID: 33305074. doi:10.1016/j.adro.2020.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。